International Opinions on Grading of Urothelial Carcinoma: A Survey Among European Association of Urology and International Society of Urological Pathology Members

Sylvester, 2021, European Association of Urology (EAU) Prognostic factor risk groups for non-muscle-invasive bladder cancer (NMIBC) incorporating the WHO 2004/2016 and WHO 1973 classification systems for grade: an update from the EAU NMIBC Guidelines Panel, Eur Urol, 79, 480, 10.1016/j.eururo.2020.12.033 Sylvester, 2002, Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials, J Urol, 168, 1964, 10.1016/S0022-5347(05)64273-5 Mostofi, 1973 Epstein, 1998, The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee, Am J Surg Pathol, 22, 1435, 10.1097/00000478-199812000-00001 Busch, 2002, The WHO/ISUP 1998 and WHO 1999 systems for malignancy grading of bladder cancer. Scientific foundation and translation to one another and previous systems, Virchows Arch, 441, 105, 10.1007/s00428-002-0633-x Bostwick, 2002, Urothelial papillary (exophytic) neoplasms, Virchows Arch, 441, 109, 10.1007/s00428-002-0624-y Humphrey, 2016, The 2016 WHO classification of tumours of the urinary system and male genital organs—part B: prostate and bladder tumours, Eur Urol, 70, 106, 10.1016/j.eururo.2016.02.028 Netto, 2022, The 2022 World Health Organization classification of tumors of the urinary system and male genital organs—part B: prostate and urinary tract tumors, Eur Urol, 82, 469, 10.1016/j.eururo.2022.07.002 Soukup, 2017, Eur Urol, 72, 801, 10.1016/j.eururo.2017.04.015 van Rhijn, 2021, Prognostic value of the WHO1973 and WHO2004/2016 classification systems for grade in primary Ta/T1 non-muscle-invasive bladder cancer: a multicenter European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel study, Eur Urol Oncol, 4, 182, 10.1016/j.euo.2020.12.002 Hentschel, 2020, Papillary urothelial neoplasm of low malignant potential (PUN-LMP): still a meaningful histo-pathological grade category for Ta, noninvasive bladder tumors in 2019?, Urol Oncol, 38, 440, 10.1016/j.urolonc.2019.10.002 van der Kwast, 2022, International Society of Urological Pathology expert opinion on grading of urothelial carcinoma, Eur Urol Focus, 8, 438, 10.1016/j.euf.2021.03.017 Bosschieter, 2018, Reproducibility and prognostic performance of the 1973 and 2004 World Health Organization classifications for grade in non-muscle-invasive bladder cancer: a multicenter study in 328 bladder tumors, Clin Genitourin Cancer, 16, e985, 10.1016/j.clgc.2018.05.002 Babjuk, 2022, European Association of Urology guidelines on non-muscle-invasive bladder cancer (Ta, T1, and carcinoma in situ), Eur Urol, 81, 75, 10.1016/j.eururo.2021.08.010 Chang, 2016, Diagnosis and treatment of non-muscle invasive bladder cancer: AUA/SUO guideline, J Urol, 196, 1021, 10.1016/j.juro.2016.06.049 Bobjer, 2022, Bladder cancer recurrence in papillary urothelial neoplasm of low malignant potential (PUNLMP) compared to G1 WHO 1999: a population-based study, Scand J Urol, 56, 14, 10.1080/21681805.2021.1987980 Downes, 2022, The impact of grading scheme on non-muscle invasive bladder cancer progression: potential utility of hybrid grading schemes, Pathology, 54, 425, 10.1016/j.pathol.2021.10.005